{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:10:16Z","timestamp":1790838616743,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016101","name":"Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease","doi-asserted-by":"publisher","award":["2020B1212060017"],"award-info":[{"award-number":["2020B1212060017"]}],"id":[{"id":"10.13039\/100016101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["CIFMS-2021-I2M-5-015"],"award-info":[{"award-number":["CIFMS-2021-I2M-5-015"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["020814380146"],"award-info":[{"award-number":["020814380146"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["020814380162"],"award-info":[{"award-number":["020814380162"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32022015"],"award-info":[{"award-number":["32022015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871295"],"award-info":[{"award-number":["31871295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20230460"],"award-info":[{"award-number":["BK20230460"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jconrel.2024.12.045","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T19:21:15Z","timestamp":1736450475000},"page":"1139-1153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease models"],"prefix":"10.1016","volume":"378","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penglu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvikhaa","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Fuehrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9680","key":"10.1016\/j.jconrel.2024.12.045_bb0005","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson\u2019s disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jconrel.2024.12.045_bb0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson\u2019s disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"issue":"9996","key":"10.1016\/j.jconrel.2024.12.045_bb0015","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson's disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"issue":"1\u20136","key":"10.1016\/j.jconrel.2024.12.045_bb0020","first-page":"344","article-title":"Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease","volume":"50","author":"Benabid","year":"1987","journal-title":"Appl. Neurophysiol."},{"issue":"7","key":"10.1016\/j.jconrel.2024.12.045_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070712","article-title":"Mitophagy in Parkinson\u2019s disease: from pathogenesis to treatment","volume":"8","author":"Liu","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.jconrel.2024.12.045_bb0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archneur.63.3.328","article-title":"Implications of genetics on the diagnosis and care of patients with Parkinson disease","volume":"63","author":"Klein","year":"2006","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jconrel.2024.12.045_bb0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s00415-020-09705-7","article-title":"Precision medicine in Parkinson\u2019s disease: emerging treatments for genetic Parkinson\u2019s disease","volume":"267","author":"Schneider","year":"2020","journal-title":"J. Neurol."},{"issue":"12","key":"10.1016\/j.jconrel.2024.12.045_bb0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrn2935","article-title":"The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson\u2019s disease","volume":"11","author":"Cookson","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.045_bb0045","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s13311-014-0284-z","article-title":"Heterogeneity of leucine-rich repeat kinase 2 mutations: genetics, mechanisms and therapeutic implications","volume":"11","author":"Rudenko","year":"2014","journal-title":"Neurotherapeutics"},{"issue":"7","key":"10.1016\/j.jconrel.2024.12.045_bb0050","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tips.2012.04.001","article-title":"Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson\u2019s disease","volume":"33","author":"Lee","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.jconrel.2024.12.045_bb0055","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neuron.2009.12.017","article-title":"Alpha-synuclein and LRRK2: partners in crime","volume":"64","author":"Tong","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.jconrel.2024.12.045_bb0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","article-title":"Recent advances in the genetics of Parkinson\u2019s disease","volume":"12","author":"Martin","year":"2011","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"2","key":"10.1016\/j.jconrel.2024.12.045_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.20731","article-title":"Lrrk2 and Lewy body disease","volume":"59","author":"Ross","year":"2006","journal-title":"Ann. Neurol."},{"issue":"6384","key":"10.1016\/j.jconrel.2024.12.045_bb0070","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.aar5683","article-title":"LRRK2 kinase in Parkinson's disease","volume":"360","author":"Alessi","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"273","key":"10.1016\/j.jconrel.2024.12.045_bb0075","doi-asserted-by":"crossref","first-page":"273ra15","DOI":"10.1126\/scitranslmed.aaa3634","article-title":"Effect of selective LRRK2 kinase inhibition on nonhuman primate lung","volume":"7","author":"Fuji","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.045_bb0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","article-title":"RNA interference: biology, mechanism, and applications","volume":"67","author":"Agrawal","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"2","key":"10.1016\/j.jconrel.2024.12.045_bb0085","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J. Biol. Med."},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.045_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nbt.1830","article-title":"SiRNA delivery with exosome nanoparticles","volume":"29","author":"van den Boorn","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2024.12.045_bb0095","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.jconrel.2024.12.045_bb0100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41580-022-00460-3","article-title":"Challenges and directions in studying cell-cell communication by extracellular vesicles","volume":"23","author":"van Niel","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6478","key":"10.1016\/j.jconrel.2024.12.045_bb0105","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"32","key":"10.1016\/j.jconrel.2024.12.045_bb0110","doi-asserted-by":"crossref","first-page":"23586","DOI":"10.1074\/jbc.M113.489302","article-title":"Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis","volume":"288","author":"Li","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.jconrel.2024.12.045_bb0115","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41422-021-00491-z","article-title":"In vivo self-assembled small RNAs as a new generation of RNAi therapeutics","volume":"31","author":"Fu","year":"2021","journal-title":"Cell Res."},{"issue":"7149","key":"10.1016\/j.jconrel.2024.12.045_bb0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","article-title":"Transvascular delivery of small interfering RNA to the central nervous system","volume":"448","author":"Kumar","year":"2007","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.045_bb0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"10.1016\/j.jconrel.2024.12.045_bb0130","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ymthe.2019.08.010","article-title":"Systemic Exosomal delivery of shRNA Minicircles prevents parkinsonian pathology","volume":"27","author":"Izco","year":"2019","journal-title":"Molecular Therapy\u202f: the Journal of the American Society of Gene Therapy"},{"issue":"10","key":"10.1016\/j.jconrel.2024.12.045_bb0135","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1089\/10430349950017734","article-title":"High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA","volume":"10","author":"Zhang","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2024.12.045_bb0140","first-page":"3","article-title":"The mechanism of naked DNA uptake and expression","volume":"54","author":"Wolff","year":"2005","journal-title":"Adv. Genet."},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.045_bb0145","article-title":"In vivo self-assembled siRNA as a modality for combination therapy of ulcerative colitis","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2024.12.045_bb0150","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1093\/brain\/awab354","article-title":"Therapeutic reversal of Huntington's disease by in vivo self-assembled siRNAs","volume":"144","author":"Zhang","year":"2021","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.045_bb0155","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cmet.2019.07.011","article-title":"Extracellular miRNAs: from biomarkers to mediators of physiology and disease","volume":"30","author":"Mori","year":"2019","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.045_bb0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","article-title":"Exosome and Exosomal MicroRNA: trafficking, sorting, and function","volume":"13","author":"Zhang","year":"2015","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"16","key":"10.1016\/j.jconrel.2024.12.045_bb0165","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"39","key":"10.1016\/j.jconrel.2024.12.045_bb0170","doi-asserted-by":"crossref","first-page":"24213","DOI":"10.1073\/pnas.2008323117","article-title":"Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides","volume":"117","author":"Geekiyanage","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2024.12.045_bb0175","first-page":"6","article-title":"Exosome-delivered microRNAs modulate the inflammatory response to endotoxin","author":"Alexander","year":"2015","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/j.jconrel.2024.12.045_bb0180","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jconrel.2024.12.045_bb0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/biomedicines10010195","article-title":"Selective isolation of liver-derived extracellular vesicles redefines performance of miRNA biomarkers for non-alcoholic fatty liver disease","volume":"10","author":"Newman","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.jconrel.2024.12.045_bb0190","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/brain\/awy077","article-title":"Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo","volume":"141","author":"Kozina","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.jconrel.2024.12.045_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuroscience.2012.02.001","article-title":"Parkinson\u2019s disease-linked leucine-rich repeat kinase 2(R1441G) mutation increases proinflammatory cytokine release from activated primary microglial cells and resultant neurotoxicity","volume":"208","author":"Gillardon","year":"2012","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.jconrel.2024.12.045_bb0200","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"issue":"3","key":"10.1016\/j.jconrel.2024.12.045_bb0205","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/ejn.14182","article-title":"The unlikely partnership between LRRK2 and \u03b1-synuclein in Parkinson\u2019s disease","volume":"49","author":"Cresto","year":"2019","journal-title":"Eur. J. Neurosci."},{"issue":"7","key":"10.1016\/j.jconrel.2024.12.045_bb0210","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson\u2019s disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat. Neurosci."},{"issue":"Suppl. 7","key":"10.1016\/j.jconrel.2024.12.045_bb0215","article-title":"Neuroimaging trials of Parkinson\u2019s disease progression","volume":"251","author":"Seibyl","year":"2004","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jconrel.2024.12.045_bb0220","first-page":"187","article-title":"Therapeutic siRNA: principles, challenges, and strategies","volume":"85","author":"Gavrilov","year":"2012","journal-title":"Yale J. Biol. Med."},{"issue":"2\u20133","key":"10.1016\/j.jconrel.2024.12.045_bb0225","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.addr.2007.03.008","article-title":"shRNA and siRNA delivery to the brain","volume":"59","author":"Pardridge","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2024.12.045_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.arr.2015.03.001","article-title":"siRNA as a tool to improve the treatment of brain diseases: mechanism, targets and delivery","volume":"21","author":"Gomes","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"11","key":"10.1016\/j.jconrel.2024.12.045_bb0235","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1093\/brain\/awab354","article-title":"Therapeutic reversal of Huntington's disease by in vivo self-assembled siRNAs","volume":"144","author":"Zhang","year":"2021","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.jconrel.2024.12.045_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122565","article-title":"Pathological functions of LRRK2 in Parkinson\u2019s disease","volume":"9","author":"Jeong","year":"2020","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.jconrel.2024.12.045_bb0245","doi-asserted-by":"crossref","first-page":"6455","DOI":"10.1111\/j.1742-4658.2009.07344.x","article-title":"LRRK2 in Parkinson\u2019s disease: genetic and clinical studies from patients","volume":"276","author":"Kumari","year":"2009","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.jconrel.2024.12.045_bb0250","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.neuroscience.2007.05.027","article-title":"A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease","volume":"147","author":"Melrose","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.jconrel.2024.12.045_bb0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fnins.2020.00443","article-title":"LRRK2 at the Interface between peripheral and central immune function in Parkinson\u2019s","volume":"14","author":"Wallings","year":"2020","journal-title":"Front. Neurosci."},{"issue":"540","key":"10.1016\/j.jconrel.2024.12.045_bb0260","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav0820","article-title":"LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits","volume":"12","author":"Baptista","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"15","key":"10.1016\/j.jconrel.2024.12.045_bb0265","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.4155\/fmc-2018-0484","article-title":"Targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of Parkinson\u2019s disease","volume":"11","author":"Domingos","year":"2019","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2024.12.045_bb0270","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1042\/BST20190236","article-title":"Parkinson\u2019s disease and mitophagy: an emerging role for LRRK2","volume":"49","author":"Singh","year":"2021","journal-title":"Biochem. Soc. Trans."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924009003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924009003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:43:29Z","timestamp":1778730209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924009003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":54,"alternative-id":["S0168365924009003"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.045","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo self-assembled siRNAs within small extracellular vesicles attenuate LRRK2-induced neurodegeneration in Parkinson's disease models","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}